Market Insights Reports

Medical Device Contract Manufacturing Market Overview The medical device contract manufacturing market is estimated to be worth $54.1 billion in 2019 and is expected to grow at CAGR of over 8% during the forecast period. Recent advances in data science technology solutions, such as Internet of Things, machine learning, artificial intelligence and real world evidence-based solutions, have enabled medical device developers to digitize and automate a number of product development and manufacturi...

Neoantigen Targeted Therapies Market Overview The global neoantigen targeted therapies market is likely to grow to $3 billion by 2030 at a CAGR of over 55%. Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2018, in the US alone.  The World Health Organization has estimated the number of new cancer cases, reported across the globe, to rise by 70% over the next 20 years.  Conventional treatment options, such as chemotherapy, surg...

Caps and Closures Market Overview The pharmaceutical caps and closures market is estimated to be worth $4.6 billion in 2019 and is expected to grow at CAGR of over 6.7% during the forecast period. Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug / th...

Clinical Trial Services Market Overview The clinical trial services market is estimated to be worth $9 billion in 2050 and is expected to grow at CAGR of over 14.1% during the forecast period. The process of developing novel and effective healthcare products is both cost and time intensive. Studies suggest that each prescription drug requires around 10 years and over USD 2.5 billion in working capital before it reaches the market. Further, it is estimated that, in the US, 40% of the pharma in...

Depressive Disorders Market Overview Depression is a chronic medical condition characterized by a persistent feeling of sadness and lack of interest in external stimuli. It is a commonly diagnosed mental health disorder and is considered among the leading causes of disability across the globe. It has been estimated that over 300 million people (considering all age groups) suffer from depression worldwide. Further, depression and other depressive disorders are projected to be responsible for a...

Companion Diagnostics Market Overview The companion diagnostics market revenue is estimated to be reach $6 billion by 2030, driven by the companion diagnostics for oncology market segment. The introduction of personalized medicine has brought about a paradigm shift within the healthcare sector. Over the years, many cases have been identified where conventional treatment options have failed to demonstrate any therapeutic benefit. It is estimated that nearly 50% of prescribed drugs / therapies...

Live Cell Encapsulation Market Overview The live cell encapsulation market is estimated to be worth $81 million in 2019 and is expected to grow at CAGR of 21% during the forecast period. Chronic disorders, such as diabetes, cancer, heart disease, obesity, and certain types of mental health problems, are considered among the leading causes of death and disability across the globe. According to a report published by the Center for Managing Chronic Disease at the University of Michigan in 201...

Bone Cement Delivery System Market Overview The bone cement delivery system market is estimated to be worth $299 million in 2019 and is expected to grow at compounded annual growth rate (CAGR) of 4.8% during the forecast period. According to a study conducted by the International Osteoporosis Foundation (IOF), more than 200 million individuals around the world suffer from osteoporosis. In fact, a total of 8.9 million fractures per year are attributed to osteoporosis, implying that an osteopor...

Metabolic and Cardiology Stem Cells Market Overview The global stem cell therapy market for cardiovascular and metabolic disorders is likely to grow to $3.3 billion by 2030, driven by the rising incidence of these disorders. Cardiovascular disorders and metabolic disorders are considered to be amongst the leading causes of death worldwide. In fact, approximately one-third of the annual number of deaths across the globe are attributed to cardiovascular disorders.  In the US, the annual...

Contact Lenses Market Overview The next generation contact lenses market is estimated to be worth $38 million in 2019 and is expected to grow at CAGR of 52% during the forecast period. For more than five decades, contact lenses have primarily been used to correct vision-related disorders. The existence of several unmet needs in the field of ophthalmology, recent technological advances and the availability of new biomaterials, have substantially expanded the range of potential application area...

Drug Delivery Technologies Market Overview The drug delivery technologies market for biologics is estimated to be worth $227 million in 2019 and is expected to grow at CAGR of 23% during the forecast period. In fact, the extent of growth of such therapies can be gauged from the fact that more than 300 biopharmaceuticals have been approved between 2002 and 2018. Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized tre...

ADME Toxicology Testing Market Overview The global in vitro ADME toxicology testing market is currently around $2.2 billion and is expected to grow at a CAGR of 9.8% till 2030. The early stages of drug discovery research, which include the identification of a relevant biological target and a viable lead compound with therapeutic potential, play a crucial role in the overall success of a drug candidate in both preclinical and clinical studies. It is also important to note that the process o...

Chronic Kidney Disease Market Overview Chronic kidney disease (CKD) is characterized by progressive loss of kidney function over a period of time. In most patients suffering from CKD, symptoms (such as swollen ankles, blood in urine and foamy urine) are rarely observed until kidney function has declined by 75%. It is worth highlighting that over 90% of the patients suffering from reduced kidney function are unaware of their medical condition.In the US, 15% of adults are reported to be sufferi...

Blockchain in Genomic Data Management Market Overview The success of the Human Genome Project resulted in the generation of large volumes of genomic data, which is extensively used in biotechnology and medical research. Further, advancements in high throughput gene sequencing technologies have enabled scientists to expedite the genome sequencing process, and achieve significant cost benefits as well. In fact, it is estimated that, by 2025, around 15% of the world’s population will have...

Medication Adherence Market Overview The medication adherence market is estimated to be worth $1.06 billion in 2018 and is expected to grow at CAGR of 23% during the forecast period. Similarly, for smart accessory devices, we expect the market to grow from $480 million to $3.1 billion by 2030. Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to be associated with negative health outcomes, inflated medical expenses, loss in productivity a...

Healthcare Cold Chain Logistics Market Overview The healthcare cold chain logistics market is estimated to be worth $1.5 billion in 2018 and is expected to grow at CAGR of 5.9% during the forecast period. The origins of the cold chain for transportation of temperature sensitive products can be traced back to 1797, when British fishermen first used natural ice to preserve their fish stock.Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transp...

Extractable and Leachable Testing Market Overview The extractable and leachable testing market is estimated to be worth $1 billion in 2028, growing at CAGR of 9.9 % during the forecast period. Harmful chemicals / contaminants from primary packaging have often been shown to migrate into pharmaceutical products, threatening the safety of several patients who use these products. For instance, in 2010, McNeil Consumer Healthcare was compelled to recall more than 500 lots of Tylenol, Motrin,...

Neurostimulation Devices Market Overview The global neurostimulation devices market is expected to increase from $3.1 billion to $USD 11 billion by 2030, growing at an annualized rate of 10.9%. The National Academy of Medicine indicates that as many as 100 million people in the US suffer from some form of pain, which has been shown to be associated with a socioeconomic burden of around USD 600 billion per year, in treatment costs and lost productivity. Further, it has been estimated that near...

Chronic Pain Treatment Market Overview The global chronic pain treatment market is estimated to be worth $7.3 billion, growing at a CAGR of 49% till 2025. Chronic pain refers to the psychophysiological response to an underlying clinical condition, which is observed to persist for a duration greater than six months and is generally unresponsive to multiple treatment regimens. It is estimated that more than 1.5 billion individuals across the world suffer from this type of pain. Some of the...

Cancer Therapeutics Market Overview The global cancer therapeutics market size is estimated to be worth $11.9 billion by 2035 and is expected to grow at CAGR of 84% during the forecast period. Cancer therapeutics continues to be one of the most active segments, in terms of drug development efforts, within the pharmaceutical industry. In fact, in the past five years, USFDA has approved more than 70 drugs for the treatment of different types of cancer. However, there is still a pressing ne...

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry